Abstract

Pathological molecular mechanisms involved in myocardial remodeling contribute to alter the existing structure of the heart, leading to cardiac dysfunction. Among the complex signaling network that characterizes myocardial remodeling, the distinct processes are myocyte loss, cardiac hypertrophy, alteration of extracellular matrix homeostasis, fibrosis, defective autophagy, metabolic abnormalities, and mitochondrial dysfunction. Several pathophysiological stimuli, such as pressure and volume overload, trigger the remodeling cascade, a process that initially confers protection to the heart as a compensatory mechanism. Yet chronic inflammation after myocardial infarction also leads to cardiac remodeling that, when prolonged, leads to heart failure progression. Here, we review the molecular pathways involved in cardiac remodeling, with particular emphasis on those associated with myocardial infarction. A better understanding of cell signaling involved in cardiac remodeling may support the development of new therapeutic strategies towards the treatment of heart failure and reduction of cardiac complications. We will also discuss data derived from gene therapy approaches for modulating key mediators of cardiac remodeling.

Highlights

  • Understanding the molecular basis of cardiac remodeling is one of the main challenges in cardiovascular medicine

  • The term cardiac remodeling was used for the first time by Hockam and Bulkley following the observation of regional dilatation and thinning of infarcted myocardium in rats [1]

  • Cardiomyocyte death is a crucial event underlying the development of cardiac dysfunction during stress and determining the progression of cardiac abnormalities overtime

Read more

Summary

Introduction

Understanding the molecular basis of cardiac remodeling is one of the main challenges in cardiovascular medicine. Multiple factors contribute to the development and progression of cardiac remodeling and LV dysfunction. Oxidative Medicine and Cellular Longevity and a progressive impairment of contractility and relaxation orchestrate together the detrimental evolution of cardiac remodeling. Alterations of proteins involved in calcium transport are responsible for cardiac remodeling, contributing to decreasing systolic and increasing diastolic calcium release and reduced contractility [4]. Neurohormonal activation, such as the reninangiotensin aldosterone system, enhances the synthesis of proteins involved in inflammation, cell death, and fibroblast proliferation [5]. We will describe the experimental evidence that suggest acting on key molecules involved in these dysregulated pathways may improve cardiac outcomes

Definition of Cardiac Remodeling in Heart Failure
Cardiac Hypertrophy
Myocardial Fibrosis
Mitochondrial Dysfunction
Autophagy Dysregulation and Apoptosis
Clinical and Translational Perspectives
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call